ArticleFrontiers in endocrinology2025
Maternal iodine levels and associations with offspring outcomes and growth: a prospective birth cohort study of Chinese pregnant women.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Iodine deficiency during pregnancy has been associated with various adverse outcomes; however, recent data on iodine status among women in Hangzhou, China, remain limited. Methods: Between 2019 and 2022, this birth cohort study enrolled 290 eligible pregnant women at ≤12 weeks of gestation. A standardized, self-developed questionnaire was used to survey each participant, covering demographic information, pregnancy details, dietary iodine intake, and related topics. Physical examination findings of each participant and their offspring were collected. Maternal urinary iodine concentration was measured in the first, second, and last trimesters of pregnancy. Offspring outcomes were evaluated by measuring weight and length at birth, 1 month, 6 months, and 18 months, along with the recording of incidences of spontaneous premature birth, small for gestational age (SGA), and low birth weight. Results: Higher maternal urinary iodine concentration (UIC) during the third trimester was found to be a protective factor against spontaneous premature birth and SGA. Similarly, elevated maternal UIC in the second trimester was identified as a protective factor against spontaneous premature birth. No significant association was observed between low birth weight and maternal UIC in the first, second, and last trimesters. However, offspring born to mothers with iodine insufficiency in the last trimester exhibited lower birth weight and length, as well as reduced length during follow-up. Additionally, offspring of mothers with iodine insufficiency in the first trimester showed lower long-term weight and length. Conclusions: These findings highlight the importance of enhanced monitoring of iodine status in pregnant women to mitigate related adverse outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.